blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2351746

EP2351746 - THE 1-BUTYL-2-HYDROXYARALKYL PIPERAZINE DERIVATIVES AND THE USES AS ANTI-DEPRESSION MEDICINE THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  18.09.2015
Database last updated on 05.10.2024
Most recent event   Tooltip22.06.2018Lapse of the patent in a contracting state
New state(s): MK		published on 25.07.2018  [2018/30]
Applicant(s)For all designated states
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.
No. 226 Huanghe Street
Shijiazhuang
Hebei 050035 / CN
For all designated states
Shanghai Institute of Pharmaceutical Industry
No. 1320 Beijing West Road
Shanghai 200040 / CN
[2014/39]
Former [2011/31]For all designated states
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.
No. 276 Zhongshan West Road Shijiazhuang
Hebei 050051 / CN
For all designated states
Shanghai Institute of Pharmaceutical Industry
No. 1320 Beijing West Road
Shanghai 200040 / CN
Inventor(s)01 / LI, Jianqi
No.1320 Beijing West Road
Shanghai 200040 / CN
02 / LV, Na
No.1320 Beijing West Road
Shanghai 200040 / CN
03 / JIN, Hua
No.1320 Beijing West Road
Shanghai 200040 / CN
04 / WENG, Zhijie
No.1320 Beijing West Road
Shanghai 200040 / CN
05 / ZHENG, Yongyong
No.1320 Beijing West Road
Shanghai 200040 / CN
 [2011/31]
Representative(s)Eisenführ Speiser
Patentanwälte Rechtsanwälte PartGmbB
Postfach 10 60 78
28060 Bremen / DE
[2014/46]
Former [2012/34]Eisenführ, Speiser & Partner
Postfach 10 60 78
28060 Bremen / DE
Former [2011/31]Eisenführ, Günther, et al
Eisenführ, Speiser & Partner Patentanwälte Rechtsanwälte Postfach 10 60 78
28060 Bremen / DE
Application number, filing date09818779.229.09.2009
[2011/31]
WO2009CN74314
Priority number, dateCN200814382107.10.2008         Original published format: CN200810043821
[2011/31]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010040315
Date:15.04.2010
Language:ZH
[2010/15]
Type: A1 Application with search report 
No.:EP2351746
Date:03.08.2011
Language:EN
[2011/31]
Type: B1 Patent specification 
No.:EP2351746
Date:12.11.2014
Language:EN
[2014/46]
Search report(s)International search report - published on:CN15.04.2010
(Supplementary) European search report - dispatched on:EP06.03.2012
ClassificationIPC:C07D295/084, A61K31/495, A61P25/24
[2011/31]
CPC:
A61K31/495 (EP,KR,US); C07D295/084 (KR); A61P25/24 (EP);
A61P43/00 (EP); C07D295/088 (EP,US); C07D295/092 (EP,KR,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2011/31]
Extension statesALNot yet paid
BANot yet paid
RSNot yet paid
TitleGerman:1-BUTYL-2-HYDROXYARALKYL-PIPERAZIN-DERIVATE UND IHRE VERWENDUNG ALS ANTIDEPRESSIVA[2011/31]
English:THE 1-BUTYL-2-HYDROXYARALKYL PIPERAZINE DERIVATIVES AND THE USES AS ANTI-DEPRESSION MEDICINE THEREOF[2011/31]
French:DÉRIVÉS DE LA 1-BUTYL-2-HYDROXYARALKYLPIPÉRAZINE ET LEURS UTILISATIONS COMME MÉDICAMENT ANTIDÉPRESSEUR[2014/20]
Former [2011/31]DÉRIVÉS DE 1-BUTYL-2-HYDROXYARALKYLPIPÉRAZINE ET LEURS UTILISATIONS COMME MÉDICAMENT ANTIDÉPRESSEUR
Entry into regional phase04.05.2011Translation filed 
09.05.2011National basic fee paid 
09.05.2011Search fee paid 
09.05.2011Designation fee(s) paid 
09.05.2011Examination fee paid 
Examination procedure21.01.2010Request for preliminary examination filed
International Preliminary Examining Authority: CN
09.05.2011Examination requested  [2011/31]
02.10.2012Amendment by applicant (claims and/or description)
15.01.2014Despatch of a communication from the examining division (Time limit: M02)
13.03.2014Reply to a communication from the examining division
15.05.2014Communication of intention to grant the patent
15.08.2014Receipt of the translation of the claim(s)
18.08.2014Fee for grant paid
18.08.2014Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  15.01.2014
Opposition(s)13.08.2015No opposition filed within time limit [2015/43]
Fees paidRenewal fee
30.09.2011Renewal fee patent year 03
01.10.2012Renewal fee patent year 04
30.09.2013Renewal fee patent year 05
30.09.2014Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU29.09.2009
AT12.11.2014
BE12.11.2014
BG12.11.2014
CY12.11.2014
CZ12.11.2014
DK12.11.2014
EE12.11.2014
ES12.11.2014
FI12.11.2014
HR12.11.2014
IT12.11.2014
LT12.11.2014
LV12.11.2014
MC12.11.2014
MK12.11.2014
MT12.11.2014
NL12.11.2014
PL12.11.2014
RO12.11.2014
SE12.11.2014
SI12.11.2014
SK12.11.2014
SM12.11.2014
TR12.11.2014
NO12.02.2015
GR13.02.2015
IS12.03.2015
PT12.03.2015
[2018/30]
Former [2017/46]HU29.09.2009
AT12.11.2014
BE12.11.2014
BG12.11.2014
CY12.11.2014
CZ12.11.2014
DK12.11.2014
EE12.11.2014
ES12.11.2014
FI12.11.2014
HR12.11.2014
IT12.11.2014
LT12.11.2014
LV12.11.2014
MC12.11.2014
MT12.11.2014
NL12.11.2014
PL12.11.2014
RO12.11.2014
SE12.11.2014
SI12.11.2014
SK12.11.2014
SM12.11.2014
TR12.11.2014
NO12.02.2015
GR13.02.2015
IS12.03.2015
PT12.03.2015
Former [2017/38]HU29.09.2009
AT12.11.2014
BG12.11.2014
CY12.11.2014
CZ12.11.2014
DK12.11.2014
EE12.11.2014
ES12.11.2014
FI12.11.2014
HR12.11.2014
IT12.11.2014
LT12.11.2014
LV12.11.2014
MC12.11.2014
MT12.11.2014
NL12.11.2014
PL12.11.2014
RO12.11.2014
SE12.11.2014
SI12.11.2014
SK12.11.2014
SM12.11.2014
TR12.11.2014
NO12.02.2015
GR13.02.2015
IS12.03.2015
PT12.03.2015
Former [2017/21]AT12.11.2014
CY12.11.2014
CZ12.11.2014
DK12.11.2014
EE12.11.2014
ES12.11.2014
FI12.11.2014
HR12.11.2014
IT12.11.2014
LT12.11.2014
LV12.11.2014
MC12.11.2014
MT12.11.2014
NL12.11.2014
PL12.11.2014
RO12.11.2014
SE12.11.2014
SI12.11.2014
SK12.11.2014
NO12.02.2015
GR13.02.2015
IS12.03.2015
PT12.03.2015
Former [2016/23]AT12.11.2014
CY12.11.2014
CZ12.11.2014
DK12.11.2014
EE12.11.2014
ES12.11.2014
FI12.11.2014
HR12.11.2014
IT12.11.2014
LT12.11.2014
LV12.11.2014
MC12.11.2014
NL12.11.2014
PL12.11.2014
RO12.11.2014
SE12.11.2014
SI12.11.2014
SK12.11.2014
NO12.02.2015
GR13.02.2015
IS12.03.2015
PT12.03.2015
Former [2016/12]AT12.11.2014
CY12.11.2014
CZ12.11.2014
DK12.11.2014
EE12.11.2014
ES12.11.2014
FI12.11.2014
HR12.11.2014
IT12.11.2014
LT12.11.2014
LV12.11.2014
NL12.11.2014
PL12.11.2014
RO12.11.2014
SE12.11.2014
SI12.11.2014
SK12.11.2014
NO12.02.2015
GR13.02.2015
IS12.03.2015
PT12.03.2015
Former [2016/03]AT12.11.2014
CY12.11.2014
CZ12.11.2014
DK12.11.2014
EE12.11.2014
ES12.11.2014
FI12.11.2014
HR12.11.2014
IT12.11.2014
LT12.11.2014
LV12.11.2014
NL12.11.2014
PL12.11.2014
RO12.11.2014
SE12.11.2014
SK12.11.2014
NO12.02.2015
GR13.02.2015
IS12.03.2015
PT12.03.2015
Former [2015/37]AT12.11.2014
CY12.11.2014
CZ12.11.2014
DK12.11.2014
EE12.11.2014
ES12.11.2014
FI12.11.2014
HR12.11.2014
LT12.11.2014
LV12.11.2014
NL12.11.2014
PL12.11.2014
RO12.11.2014
SE12.11.2014
SK12.11.2014
NO12.02.2015
GR13.02.2015
IS12.03.2015
PT12.03.2015
Former [2015/36]AT12.11.2014
CY12.11.2014
CZ12.11.2014
DK12.11.2014
EE12.11.2014
ES12.11.2014
FI12.11.2014
HR12.11.2014
LT12.11.2014
LV12.11.2014
NL12.11.2014
PL12.11.2014
RO12.11.2014
SE12.11.2014
NO12.02.2015
GR13.02.2015
IS12.03.2015
PT12.03.2015
Former [2015/35]AT12.11.2014
CY12.11.2014
DK12.11.2014
EE12.11.2014
ES12.11.2014
FI12.11.2014
HR12.11.2014
LT12.11.2014
LV12.11.2014
NL12.11.2014
PL12.11.2014
SE12.11.2014
NO12.02.2015
GR13.02.2015
IS12.03.2015
PT12.03.2015
Former [2015/34]AT12.11.2014
CY12.11.2014
DK12.11.2014
ES12.11.2014
FI12.11.2014
HR12.11.2014
LT12.11.2014
LV12.11.2014
NL12.11.2014
PL12.11.2014
SE12.11.2014
NO12.02.2015
GR13.02.2015
IS12.03.2015
PT12.03.2015
Former [2015/26]AT12.11.2014
CY12.11.2014
ES12.11.2014
FI12.11.2014
HR12.11.2014
LT12.11.2014
LV12.11.2014
NL12.11.2014
PL12.11.2014
SE12.11.2014
NO12.02.2015
GR13.02.2015
IS12.03.2015
PT12.03.2015
Former [2015/25]AT12.11.2014
ES12.11.2014
FI12.11.2014
HR12.11.2014
LT12.11.2014
LV12.11.2014
NL12.11.2014
PL12.11.2014
SE12.11.2014
NO12.02.2015
GR13.02.2015
IS12.03.2015
PT12.03.2015
Former [2015/24]ES12.11.2014
FI12.11.2014
HR12.11.2014
LT12.11.2014
LV12.11.2014
NL12.11.2014
PL12.11.2014
SE12.11.2014
NO12.02.2015
GR13.02.2015
IS12.03.2015
PT12.03.2015
Former [2015/23]ES12.11.2014
FI12.11.2014
LT12.11.2014
NL12.11.2014
NO12.02.2015
IS12.03.2015
PT12.03.2015
Former [2015/22]LT12.11.2014
NO12.02.2015
PT12.03.2015
Former [2015/21]LT12.11.2014
NO12.02.2015
Former [2015/20]LT12.11.2014
Documents cited:Search[I]US2005267121  (LI JIANQI [CN], et al) [I] 1-11 * abstract * * clims ** page 3 - page 4 *
International search[A]CN1381448  (SHANGHAI ACADEMY OF MEDICAL IN [CN]);
 [A]CN1384102  (SHANGHAI INST OF MEDICINAL IND [CN]);
 [A]CN1948297  (SHANGHAI INST OF MEDICINE INDU [CN])
by applicantUS4748726
    - ZHANG JUNTIAN, Modern Pharmacological Experiments Mothods, BEIJING MEDICAL UNIVERSITY AND PEKING UNION MEDICAL UNIVERSITY JOINT PUBLISHING HOUSE, (1998), pages 1064 - 1066
    - ZHANG JUNTIAN, Modern Pharmacological Experiments Mothods, BEIJING MEDICAL UNIVERSITY AND PEKING UNION MEDICAL UNIVERSITY JOINT PUBLISHING HOUSE, (1998), pages 1818 - 1821
 CN20021011934
 CN20051030354
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.